Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 14, 2017
Lower cerebral blood flow in subjects with Alzheimer's dementia, mild cognitive impairment, and subjective cognitive decline using two-dimensional phase-contrast magnetic resonance imagingJolien F Leijenaar, Ingrid S van Maurik, Joost P A Kuijer, et al.
Alzheimer'S Research & Therapy|September 2, 2019
ABIDE Delphi study: topics to discuss in diagnostic consultations in memory clinicsAgnetha D Fruijtier, Leonie N C Visser, Ingrid S van Maurik, et al.
Alzheimer'S Research & Therapy|April 15, 2023
Steeper memory decline after COVID-19 lockdown measuresEls D Bakker, Stéphanie L van der Pas, Marissa D Zwan, et al.
Alzheimer'S Research & Therapy|January 8, 2021
Biomarker testing in MCI patients-deciding who to testIngrid S van Maurik, Hanneke F M Rhodius-Meester, Charlotte E Teunissen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 8, 2019
Added value of amyloid PET in individualized risk predictions for MCI patientsIngrid S van Maurik, Laura M van der Kall, Arno de Wilde, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 30, 2024
Impact of COVID-19 pandemic on mortality rate in memory clinic patientsEls D Bakker, Ingrid S van Maurik, Marissa D Zwan, et al.
JAMA Neurology|October 20, 2017
Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) ProjectIngrid S van Maurik, Marissa D Zwan, Betty M Tijms, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 6, 2025
Long-term cost-effectiveness of a more accurate diagnostic work-up for dementiaPieter J van der Veere, Hana M Broulikova, Jeroen Hoogland, et al.
American Journal of Obstetrics and Gynecology|June 7, 2025
Optimal follow-up strategy using high-risk human papillomavirus testing and cytology after conservative treatment for cervical adenocarcinoma in situMirte Schaafsma, Teska N Schuurman, Ingrid S van Maurik, et al.
Alzheimer'S Research & Therapy|August 5, 2022
Development of multivariable prediction models for institutionalization and mortality in the full spectrum of Alzheimer's diseaseArenda Mank, Ingrid S van Maurik, Judith J M Rijnhart, et al.
Pageof 4